EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cell-Derived Nanocarriers of Apoptotic Bodies with an Antimicrobial Peptide for Targeting Intracellular S. aureus Infections

Valentina Nieto-Marín iD, Ian Alejandro Fernandez-Soliz, Jorge William Arboleda Valencia, Daniel Pletzer iD, Danieli Fernanda Buccini, Octávio Luiz Franco iD

ACS Applied Bio Materials · 2025

DOI: 10.1021/acsabm.5c01222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Valentina Nieto-Marín und 5 weiteren Autor:innen. Beteiligte Einrichtung: S-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil. Hauptthemen laut MEDLINE: Staphylococcus aureus, Antimicrobial Peptides, Staphylococcal Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Apoio à Pesquisa do Distrito Federal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intracellular infections caused by Staphylococcus aureus are challenging due to their ability to evade host defenses, through the development of small colony variants (SCVs) that are resistant to conventional therapies. This study yielded and evaluated size-remodeled apoptotic bodies (ReApoBDs) as cell-derived nanocarriers for the targeted delivery of BotrAMP14, an antimicrobial peptide, to treat S. aureus-infected macrophages. ReApoBDs demonstrated high encapsulation efficiencies (∼70%), biocompatibility, sustained drug release over 12 h, colloidal stability, and improved intracellular delivery. The ReApoBDs-BotrAMP14 nanoformulation reduced intracellular bacterial loads while exhibiting lower cytotoxicity compared to the free peptide. Moreover, in vivo experiments demonstrated that ReApoBD-BotrAMP14 reduced dermonecrosis by 31.7% and SCV prevalence by 72.9%, more effectively than conventional treatments in a skin abscess model. Finally, the positive correlation between cell viability and bacterial survival highlights the challenge of designing treatments that effectively eliminate intracellular bacteria while preserving host cell integrity. As the first study to develop a ReApoBD-AMP formulation, these findings position ReApoBD-BotrAMP14 as a groundbreaking platform for treating persistent intracellular infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusAntimicrobial PeptidesStaphylococcal InfectionsAnti-Bacterial AgentsDrug CarriersBiocompatible MaterialsNanoparticlesAnimalsMiceApoptosisMicrobial Sensitivity TestsMaterials TestingParticle SizeHumansCell Survival

Stichwörter der Autor:innen

bacteriadrug deliveryextracellular vesiclesintracellular infectionsmacrophagesnanotechnology

Substanzen

Antimicrobial PeptidesAnti-Bacterial AgentsDrug CarriersBiocompatible Materials

Autor:innen und Institutionen

  • S-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul 79117-900, Brazil.
  • Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, Otago 9054, New Zealand.
  • Grupo de Investigación FITOBIOL, Instituto de Biología, Facultad de Ciencias Exactas y Naturales, Universidad de Antioquia, Medellín, Antioquia 050010, Colombia.
  • Laboratorio HERSSEN─Grupo de Investigación en Medicina Integrativa y Fitomedicina, Manizales, Caldas 170002, Colombia.
  • Centro de Investigaciones en Medio Ambiente y Desarrollo-CIMAD, Universidad de Manizales, Manizales, Caldas 170001, Colombia.
  • Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Distrito Federal 71966-700, Brazil.

ORCID-Profile: Valentina Nieto-Marín, Daniel Pletzer, Octávio Luiz Franco

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Apoio à Pesquisa do Distrito Federal
  • Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul

Zitieren

APA

Nieto-Marín, V., Fernandez-Soliz, I. A., Arboleda Valencia, J. W., Pletzer, D., Buccini, D. F., & Franco, O. L. (2025). Cell-Derived Nanocarriers of Apoptotic Bodies with an Antimicrobial Peptide for Targeting Intracellular S. aureus Infections. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c01222

Vancouver

Nieto-Marín V, Fernandez-Soliz IA, Arboleda Valencia JW, Pletzer D, Buccini DF, Franco OL. Cell-Derived Nanocarriers of Apoptotic Bodies with an Antimicrobial Peptide for Targeting Intracellular S. aureus Infections. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c01222

BibTeX
@article{NietoMarn2025,
  author = {Nieto-Marín, Valentina and Fernandez-Soliz, Ian Alejandro and Arboleda Valencia, Jorge William and Pletzer, Daniel and Buccini, Danieli Fernanda and Franco, Octávio Luiz},
  title = {Cell-Derived Nanocarriers of Apoptotic Bodies with an Antimicrobial Peptide for Targeting Intracellular S. aureus Infections},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  doi = {10.1021/acsabm.5c01222}
}
Kostenlos starten →